GRK5 and hydrops fetalis: Our results show that HF patients with GRK5 Leu41 variant in its homozygous and heterozygous forms show decreased events in hospitalization and specifically respond to β-blockers and require reduced β-blocker drug dosage in comparison to GRK5 Gln41 carriers.